This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Quan, N. Articles by Weiss, J. M. Search for Related Content PubMed PubMed Citation Articles by Quan, N. Articles by Weiss, J. M.

Evidence for Involvement of B Lymphocytes in the Surveillance of Lung Metastasis in the Rat¹

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322 [Z-b. Z., M. K. D., J. M. W.]; Department of Pathology, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213 [W. H. C.]; Department of Molecular Biology and Immunology, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas 76107 [R. P. K., R. H. G.]; and National Institute of Mental Health, Section on Functional Neuroanatomy, Bethesda, Maryland 20892 [N. Q.]

These studies examined the composition of lymphocytes within the lung after the introduction of tumor cells that metastasize to the lung in rats. i.v. delivery of MADB106 tumor cells into syngeneic Fischer 344 rats caused dose- and time-dependent development of lung tumors, with surface metastases evident 7 days after injection and markedly increased 11 days after injection. The total number of lymphocytes recovered from the lung was increased 11 days after injection but not 7 days after injection. When lymphocytes from the lung, spleen, and blood were subjected to fluorescence-activated cell sorting analysis, the most conspicuous change was an increase in the percentage of CD45RA+ cells (i.e., B lymphocytes in the rat) in the lung, with no changes seen in the percentage of natural killer (NKR-P1+), CD4+, or CD8+ cells in the lung. Analysis of the time course showed that B lymphocytes increased in the lung soon after i.v. tumor injection, with an initial peak seen 6 h after injection. Rapid influx of B lymphocytes into lung after i.v. tumor cell injection was also observed in another syngeneic tumor model, i.e., after injection of CC531 cells into WAG rats. To determine whether the influx of B lymphocytes into the lung might participate in tumor surveillance, a high dose of antibody (100 µg) to rat B lymphocytes was given to immunoneutralize these cells; this produced an increase in lung tumors in both models. Finally, Fischer 344 rats were given a s.c. injection of MADB106 tumor cells that made them resistant to lung tumors when given a later i.v. injection of these tumor cells. These animals were found to have an elevated level of B lymphocytes residing in the lung associated with the resistance to lung tumor. These findings suggest that early responses of B lymphocytes are important in protection against tumor development in two rat models of cancer.

This article has been cited by other articles:

				A. Sadlonova, S. Mukherjee, D. B. Bowe, S. R. Gault, N. A. Dumas, B. A. Van Tine, N. Frolova, G. P. Page, D. R. Welch, L. Novak, et al. Human Breast Fibroblasts Inhibit Growth of the MCF10AT Xenograft Model of Proliferative Breast Disease Am. J. Pathol., March 1, 2007; 170(3): 1064 - 1076. [Abstract] [Full Text] [PDF]

				B. Kotlan, P. Simsa, J.-L. Teillaud, W. H. Fridman, J. Toth, M. McKnight, and M. C. Glassy Novel Ganglioside Antigen Identified by B Cells in Human Medullary Breast Carcinomas: The Proof of Principle Concerning the Tumor-Infiltrating B Lymphocytes J. Immunol., August 15, 2005; 175(4): 2278 - 2285. [Abstract] [Full Text] [PDF]

				C. M.L. van Herpen, J. A.W.M. van der Laak, I. J. M. de Vries, J. H. van Krieken, P. C. de Wilde, M. G.J. Balvers, G. J. Adema, and P. H.M. De Mulder Intratumoral Recombinant Human Interleukin-12 Administration in Head and Neck Squamous Cell Carcinoma Patients Modifies Locoregional Lymph Node Architecture and Induces Natural Killer Cell Infiltration in the Primary Tumor Clin. Cancer Res., March 1, 2005; 11(5): 1899 - 1909. [Abstract] [Full Text] [PDF]

				L. A. Augusto, M. Synguelakis, Q. Espinassous, M. Lepoivre, J. Johansson, and R. Chaby Cellular Antiendotoxin Activities of Lung Surfactant Protein C in Lipid Vesicles Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 335 - 341. [Abstract] [Full Text] [PDF]

				M. K. Demetrikopoulos, R. H. Goldfarb, Z.-b. Zhang, and J. M. Weiss Blood Level of B and CD4+ Lymphocytes Measured before Induction of an Experimental Tumor in Rats Predicts Tumor Progression and Survival Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 609 - 617. [Abstract] [Full Text]

				J. S. Jacobson, S. B. Workman, and F. Kronenberg Research on Complementary/Alternative Medicine for Patients With Breast Cancer: A Review of the Biomedical Literature J. Clin. Oncol., February 1, 2000; 18(3): 668 - 668. [Abstract] [Full Text] [PDF]